Adhera Therapeutics Eulerpool News

Adhera Therapeutics Eulerpool News

Adhera Therapeutics Notizie Azioni

Adhera Therapeutics è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Adhera Therapeutics.

• 12 febbraio ·

  GuruFocus
  Adhera Therapeutics Inc Annual Shareholders Meeting Transcript
• 27 novembre ·

  MarketWatch
  Biodexa Pharma Shares Double After Licensing Deal for Tolimidone
• 27 novembre ·

  MarketWatch
  Biodexa Enters Worldwide Licensing Deal for Tolimidone
• 25 gennaio ·

  Yahoo
  Adhera Therapeutics to Collaborate with Alberta Diabetes Institute, University of Alberta to Initiate Clinical Trial of MLR-1023 in Type 1 Diabetes
• 5 dicembre ·

  Seeking Alpha
  Adhera Therapeutics files for Nasdaq uplisting, $35M offering
• 7 ottobre ·

  DowJones
  U.S. stocks end sharply lower after strong jobs report keeps Fed on hiking path, but post gain for week
• 3 ottobre ·

  DowJones
  Bear Market Playbook - MarketWatch
• 26 settembre ·

  DowJones
  He ‘house hacked’ his way to wealth, and now plans to build a mansion - MarketWatch
• 23 settembre ·

  DowJones
  Building Generational Wealth - MarketWatch
• 19 settembre ·

  Yahoo
  Adhera Therapeutics Announces CEO, Senior Management Changes, Plans for NASDAQ Uplist